Modulation of Carbon Nanotubes' Perturbation to the Metabolic Activity of CYP3A4 in the Liver

The high accumulation of multiwalled carbon nanotubes (MWCNTs) in the liver results in their internalization in hepatic cells and perturbations to CYP enzymes, including CYP3A4. Surface chemical modifications on MWCNTs cause enhancement, inhibition, or no effect in CYP3A4 activity. Computational analysis identifies chemical structures on the surface modifications that induce CYP3A4 inhibition or prevent its perturbation.

[1]  T. E. Gram.  [21] Separation of hepatic smooth and rough microsomes associated with drug-metabolizing enzymes , 1974 .

[2]  K. Chen,et al.  Interaction of multiwalled carbon nanotubes with supported lipid bilayers and vesicles as model biological membranes. , 2013, Environmental science & technology.

[3]  Guibin Jiang,et al.  Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity. , 2011, ACS nano.

[4]  T. Umbreit,et al.  Tissue distribution and histopathological effects of titanium dioxide nanoparticles after intravenous or subcutaneous injection in mice , 2012, Journal of applied toxicology : JAT.

[5]  H. Dai,et al.  Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. , 2008, Journal of the American Chemical Society.

[6]  Rawiwan Maniratanachote,et al.  Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity , 2012, Xenobiotica; the fate of foreign compounds in biological systems.

[7]  Weibo Cai,et al.  Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[8]  L. Tang,et al.  Size- and time-dependent alteration in metabolic activities of human hepatic cytochrome P450 isozymes by gold nanoparticles via microsomal coincubations , 2014, Nanoscale Research Letters.

[9]  William W. Yu,et al.  Quantitative determination of skin penetration of PEG-coated CdSe quantum dots in dermabraded but not intact SKH-1 hairless mouse skin. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[10]  Malcolm L. H. Green,et al.  Filled and glycosylated carbon nanotubes for in vivo radioemitter localization and imaging. , 2010, Nature materials.

[11]  U. Vogel,et al.  Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate , 2011, Particle and Fibre Toxicology.

[12]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[13]  Mandy B. Esch,et al.  Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury. , 2014, Lab on a chip.

[14]  J. Leszczynski,et al.  A new approach to the characterization of nanomaterials : Predicting Young's modulus by correlation weighting of nanomaterials codes , 2006 .

[15]  Chin-Tu Chen,et al.  Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy. , 2012, ACS nano.

[16]  Yi Zhang,et al.  The effect of multiwalled carbon nanotube agglomeration on their accumulation in and damage to organs in mice , 2009 .

[17]  G. Tobias,et al.  Filled carbon nanotubes in biomedical imaging and drug delivery , 2015, Expert opinion on drug delivery.

[18]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[19]  D. Waxman,et al.  P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. , 1999, Archives of biochemistry and biophysics.

[20]  N. Altman.  An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression , 1992 .

[21]  Xizhong Shen,et al.  The hepatotoxicity of multi-walled carbon nanotubes in mice , 2009, Nanotechnology.

[22]  Meng Wang,et al.  Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[23]  Mark E. Davis,et al.  A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. , 2005, Bioconjugate chemistry.

[24]  Toru Negishi,et al.  Metabolic Activation of Benzodiazepines by CYP3A4 , 2009, Drug Metabolism and Disposition.

[25]  Z. Chai,et al.  Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. , 2007, Toxicology letters.

[26]  C. Flück,et al.  Reduction in hepatic drug metabolizing CYP3A4 activities caused by P450 oxidoreductase mutations identified in patients with disordered steroid metabolism. , 2010, Biochemical and biophysical research communications.

[27]  A. Atala,et al.  Carbon nanotube applications for tissue engineering. , 2007, Biomaterials.

[28]  Hongyu Zhou,et al.  A nano-combinatorial library strategy for the discovery of nanotubes with reduced protein-binding, cytotoxicity, and immune response. , 2008, Nano letters.

[29]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[30]  Robert Sinclair,et al.  Preclinical evaluation of Raman nanoparticle biodistribution for their potential use in clinical endoscopy imaging. , 2011, Small.

[31]  Gregory W. Kauffman,et al.  QSAR and k-Nearest Neighbor Classification Analysis of Selective Cyclooxygenase-2 Inhibitors Using Topologically-Based Numerical Descriptors , 2001, J. Chem. Inf. Comput. Sci..

[32]  Wei Liu,et al.  Protein Binding by Functionalized Multiwalled Carbon Nanotubes Is Governed by the Surface Chemistry of Both Parties and the Nanotube Diameter , 2008 .

[33]  Wolfgang J Parak,et al.  A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. , 2009, Nature nanotechnology.

[34]  A. Florence,et al.  Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency , 1990, The Journal of pharmacy and pharmacology.

[35]  Yuepu Pu,et al.  Effects of Subchronic Exposure to Multi-Walled Carbon Nanotubes on Mice , 2010, Journal of toxicology and environmental health. Part A.

[36]  Daniel G. Anderson,et al.  Therapeutic siRNA silencing in inflammatory monocytes , 2011, Nature Biotechnology.

[37]  A. Sereemaspun,et al.  Inhibition of Human Cytochrome P450 Enzymes by Metallic Nanoparticles: A Preliminary to Nanogenomics , 2008 .

[38]  M. Munger,et al.  Nanosilver Particle Effects on Drug Metabolism In Vitro , 2010, Drug Metabolism and Disposition.

[39]  J. Idle,et al.  Rifampicin-Activated Human Pregnane X Receptor and CYP3A4 Induction Enhance Acetaminophen-Induced Toxicity , 2009, Drug Metabolism and Disposition.

[40]  A. Moreira,et al.  Long-Term Inhalation Exposure to Nickel Nanoparticles Exacerbated Atherosclerosis in a Susceptible Mouse Model , 2010, Environmental health perspectives.

[41]  Jerzy Leszczynski,et al.  Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.

[42]  H. Ali-Boucetta,et al.  Pharmacology of carbon nanotubes: toxicokinetics, excretion and tissue accumulation. , 2013, Advanced drug delivery reviews.

[43]  Tonghua Wang,et al.  Translocation and fate of multi-walled carbon nanotubes in vivo , 2007 .

[44]  Munir Pirmohamed,et al.  Cytochrome P450 enzyme polymorphisms and adverse drug reactions. , 2003, Toxicology.

[45]  Zahi A Fayad,et al.  The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis. , 2011, Biomaterials.

[46]  Minghong Wu,et al.  Long-term hepatotoxicity of polyethylene-glycol functionalized multi-walled carbon nanotubes in mice. , 2010, Nanotechnology.

[47]  M. Prato,et al.  Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. , 2008, Nanomedicine.

[48]  Peter Wick,et al.  Pulmonary surfactant coating of multi-walled carbon nanotubes (MWCNTs) influences their oxidative and pro-inflammatory potential in vitro , 2012, Particle and Fibre Toxicology.

[49]  P. Beaune,et al.  Cytochromes P-450 in human hepatocyte plasma membrane: recognition by several autoantibodies. , 1993, Gastroenterology.

[50]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[51]  Alexander Tropsha,et al.  Chemical basis of interactions between engineered nanoparticles and biological systems. , 2014, Chemical reviews.

[52]  T. Pieber,et al.  Size-dependent effects of nanoparticles on the activity of cytochrome P450 isoenzymes. , 2010, Toxicology and applied pharmacology.